...
首页> 外文期刊>International journal of gynecological cancer: official journal of the International Gynecological Cancer Society >One-year follow-up of single-visit approach to cervical cancer prevention based on visual inspection with acetic acid wash and immediate cryotherapy in rural Thailand.
【24h】

One-year follow-up of single-visit approach to cervical cancer prevention based on visual inspection with acetic acid wash and immediate cryotherapy in rural Thailand.

机译:在泰国农村地区,通过目视检查,乙酸清洗和立即冷冻疗法,对宫颈癌的单次就诊方法进行了为期一年的随访。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim is to evaluate 1) the visibility of cervical squamocolumnar junction (SCJ) after cryotherapy treatment and 2) to evaluate the effectiveness of cryotherapy treatment originally performed as part of a safety, acceptability, and feasibility (SAFE) demonstration project evaluating the SAFE of visual inspection with acetic acid (VIA) followed by immediate offer of cryotherapy among those who were tested positive and eligible for treatment. A total of 704 women presented at 1-year follow-up exam during which VIA was performed again by nurses. Six hundred and forty eight (92.0%) women received colposcopy and any kind of biopsy, if indicated, by trained physician colposcopists at a referral hospital. At 1 year, VIA nurses assessed 42 of 648 referred women (6.5%) as abnormal (test positive or suspected cancer). The SCJ was visible to the colposcopists in 91.7% (594/648) of the women. Among 42 women assessed as abnormal by the nurses, colposcopic findings were abnormal in 83.3% (35/42), with one low-grade squamous intraepithelial lesion, two high-grade squamous intraepithelial lesion (HSIL), and one adenocarcinoma confirmed later by biopsy. Among 606 VIA negative women, colposcopy was abnormal in only 23.4% (142/606), with two cases of HSIL confirmed later. Given that the SCJ was visible in the vast majority of women (91.7%) after cryotherapy, VIA could be used to provide follow-up for women previously treated. The disease negative rate after cryotherapy (no human papillomavirus infection, no cervical intraepithelial neoplasia, and no cancer) at 1 year after treatment was 85.5% (554/648).
机译:目的是评估1)冷冻治疗后宫颈鳞状上皮交界处(SCJ)的可见度,以及2)评估最初作为评估安全性,可接受性和可行性(SAFE)示范项目的一部分进行的冷冻治疗的有效性。在被测试为阳性并符合治疗条件的患者中,进行乙酸(VIA)视觉检查,然后立即提供冷冻治疗。总共704名妇女参加了为期1年的随访检查,在此期间护士再次进行了VIA检查。 648名(92.0%)妇女接受了转诊医院经阴道镜检查的阴道镜检查和任何活检(如果有指示)。在1年时,VIA护士评估了648名转诊妇女中的42名(6.5%)为异常(测试阳性或可疑癌症)。协作者在91.7%(594/648)的妇女中可以看到SCJ。在42名经护士评估为异常的女性中,阴道镜检查发现的异常率为83.3%(35/42),其中1例为低度鳞状上皮内病变,2例为高度鳞状上皮内病变(HSIL)和1例腺癌,随后经活检证实。在606名VIA阴性女性中,只有23.4%(142/606)的阴道镜检查异常,随后有2例HSIL确诊。鉴于冷冻疗法后绝大多数女性中可见SCJ(91.7%),因此VIA可用于为先前接受过治疗的女性提供随访。治疗后1年,冷冻治疗后的疾病阴性率(无人乳头瘤病毒感染,无宫颈上皮内瘤变和无癌)为85.5%(554/648)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号